Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schäfer-Korting

Showing results (61-70 of 212) with videos related to

Pageof 22
Sort By:
Drug Discovery Today|December 15, 2010
In vitro models for human skin diseaseLydia Semlin, Monika Schäfer-Korting, Claudia Borelli, et al.
Drugs|September 16, 2005
Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?Günther Weindl, Monika Schäfer-Korting, Martin Schaller, et al.
American Journal of Clinical Dermatology|November 28, 2007
Sphingosine-1-phosphate signaling and the skinThomas Herzinger, Burkhard Kleuser, Monika Schäfer-Korting, et al.
Skin Pharmacology and Physiology|September 29, 2004
Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspectsG Weindl, M Schaller, M Schäfer-Korting, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1984
Ketoconazole concentrations in human skin blister fluid and plasmaM Schäfer-Korting, H C Korting, M Dorn, et al.
The Clinical Investigator|August 1, 1993
Influence of topical erythromycin preparations for acne vulgaris on skin surface pHH C Korting, M Kerscher, M Schäfer-Korting, et al.
Acta Dermato-Venereologica|January 1, 1987
Can the clinical efficacy of different antibiotic dosage regimens in gonorrhoea be predicted from the gonocidal effect of the corresponding plasma level profiles simulated in vitro?H C Korting, M Ollert, A Lukacs, et al.
Skin Pharmacology and Physiology|December 21, 2004
Safety and efficacy of fluticasone propionate in the topical treatment of skin diseasesA Roeder, M Schaller, M Schäfer-Korting, et al.
Skin Pharmacology and Applied Skin Physiology|October 7, 2003
Testosterone metabolism in human skin cells in vitro and its interaction with estradiol and dutasterideU Münster, S Hammer, U Blume-Peytavi, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1990
Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteersR Warlich, H C Korting, M Schäfer-Korting, et al.
Pageof 22

Showing results (61-70 of 212) with videos related to

Sort By:
Pageof 22
Drug Discovery Today|December 15, 2010
In vitro models for human skin diseaseLydia Semlin, Monika Schäfer-Korting, Claudia Borelli, et al.
Drugs|September 16, 2005
Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?Günther Weindl, Monika Schäfer-Korting, Martin Schaller, et al.
American Journal of Clinical Dermatology|November 28, 2007
Sphingosine-1-phosphate signaling and the skinThomas Herzinger, Burkhard Kleuser, Monika Schäfer-Korting, et al.
Skin Pharmacology and Physiology|September 29, 2004
Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspectsG Weindl, M Schaller, M Schäfer-Korting, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1984
Ketoconazole concentrations in human skin blister fluid and plasmaM Schäfer-Korting, H C Korting, M Dorn, et al.
The Clinical Investigator|August 1, 1993
Influence of topical erythromycin preparations for acne vulgaris on skin surface pHH C Korting, M Kerscher, M Schäfer-Korting, et al.
Acta Dermato-Venereologica|January 1, 1987
Can the clinical efficacy of different antibiotic dosage regimens in gonorrhoea be predicted from the gonocidal effect of the corresponding plasma level profiles simulated in vitro?H C Korting, M Ollert, A Lukacs, et al.
Skin Pharmacology and Physiology|December 21, 2004
Safety and efficacy of fluticasone propionate in the topical treatment of skin diseasesA Roeder, M Schaller, M Schäfer-Korting, et al.
Skin Pharmacology and Applied Skin Physiology|October 7, 2003
Testosterone metabolism in human skin cells in vitro and its interaction with estradiol and dutasterideU Münster, S Hammer, U Blume-Peytavi, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1990
Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteersR Warlich, H C Korting, M Schäfer-Korting, et al.
Pageof 22